07:00 , Apr 5, 2004 |  BioCentury  |  Tools & Techniques

The double-barreled approach

Newly formed PainCeptor Pharma Corp. brings together two small Canadian pain companies, each of which was focused on a different target. NeuroCeptor Inc., a spinout from Queens University, was studying the role of neurotrophins, specifically...
08:00 , Mar 29, 2004 |  BioCentury  |  Finance

Ebb & Flow

While the IPOs sails drooped in the U.S., Basilea (SWX:BSLN) - one of Europe's leading spinout companies - made it to market last week and commanded a market cap of more than a half a...
08:00 , Mar 22, 2004 |  BC Extra  |  Financial News

PainCeptor raises C$23 million

PainCeptor (Montreal, Quebec) raised C$23 million (US$17.2 million) in a private round led by CDP Capital. Other investors included the Business Development Bank of Canada; Desjardins; Canadian Medical Discoveries Fund; T2C2/ S*BIO 2000; MDS Capital;...